GeneDx Holdings
108 hedge funds and large institutions have $337M invested in GeneDx Holdings in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 31 reducing their positions, and 23 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
26% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 31
0.01% less ownership
Funds ownership: 1.38% → 1.37% (-0.01%)
4% less funds holding
Funds holding: 112 → 108 (-4)
17% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 23
31% less capital invested
Capital invested by funds: $487M → $337M (-$150M)
38% less call options, than puts
Call options by funds: $3.61M | Put options by funds: $5.81M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$13.3M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$9.62M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.5M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.38M |
| 5 |
GS
Gagnon Securities
New York
|
+$3.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$13M |
| 2 |
Alkeon Capital Management
New York
|
-$11.4M |
| 3 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$7.61M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$5.47M |
| 5 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
-$5.29M |
WGS Hedge Fund Activity: Q1 2022 in Review
108 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q1 2022, worth a combined $337M — down 31% from $487M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of WGS and 19 opened new positions — a net loss of 4 holders — while 31 trimmed existing stakes and 39 added.
The largest buyer was Oracle Investment Management, opening a new position worth an estimated $13.3M. The largest seller was Morgan Stanley, cutting an estimated $13M.
- 108 institutional investors held GeneDx Holdings (WGS) as of Q1 2022, down from 112 in Q4 2021.
- Funds reported $337M of GeneDx Holdings stock for Q1 2022, down 31% quarter-over-quarter.
- 19 funds opened new GeneDx Holdings positions in Q1 2022 and 23 closed out, a net change of -4 holders.
- The largest GeneDx Holdings buyer in Q1 2022 was Oracle Investment Management, an estimated $13.3M added.
- The largest GeneDx Holdings seller in Q1 2022 was Morgan Stanley, an estimated $13M sold.
Based on aggregated 13F filings for Q1 2022.